Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Drug Industry Avoids FDA's "Blunt Tools" With Safe Use Initiative Progress

This article was originally published in The Tan Sheet

Executive Summary

Efforts by firms and other pharmaceutical industry stakeholders to drive FDA's Safe Use Initiative agenda lower the likelihood of the agency intervening with enforcement action, according to Principal Deputy Commissioner Josh Sharfstein
Advertisement

Related Content

Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says
Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says
Dosing Directions, Measuring Devices Vary For OTC Meds, JAMA Study Says
Safe Use workshop set
McNeil Exec Calls For Uniform Use Of "Acetaminophen" Name
OTC Dosing Device Guidance Elicits Concern On Spoon Confusion, Added Cost
FDA Launches Safe Use Initiative; Details TBA Following Stakeholder Input
Lower Acetaminophen Doses Recommended Despite Cost Impact, Lack Of Data
Firms Consult FDA, Add “Do Not Use” For Under 4 To Pediatric Cold Products
Firms Consult FDA, Add “Do Not Use” For Under 4 To Pediatric Cold Products

Topics

Advertisement
UsernamePublicRestriction

Register

PS104086

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel